iSBTc Annual Meeting and Associated Programs - Only weeks away!
Register now for the iSBTc 23rd Annual Meeting and Associated Programs!
October 29-November 2, 2008
Westin Gaslamp Quarter Hotel
San Diego, CA
Program Highlights
Global Regulatory Summit on Oncology Biologics Development
October 29, 2008 - San Diego, CA
Brings together leaders from world-wide regulatory agencies to give perspective and facilitate discussion on regulatory considerations in the development of oncology biologics products.
Countries Presenting:
USA, Canada, Europe, Japan, India, Switzerland, China
Confirmed Faculty:
Ashok M. Batra, MD - US Food and Drug Administration, CBER
Patrick Celis, PhD - European Medicines Agency
Gina Coleman, MD - Health Canada
Bindu Dey, PhD - Department of Biotechnology, Government of India
Thomas Hinz, PhD - Paul-Ehrlich-Institut, Germany
Luo Jianhui, MD - Center for Drug Evaluation, SFDA, P.R. China
Koji Kawakami, MD, PhD - Japan Science and Technology Agency
Samir Khleif, MD - National Cancer Institute
Ke Liu, MD, PhD - US Food and Drug Administration, CBER
Andreas Marti, PD, PhD - Swissmedic, Swiss Agency for Therapeutic Products
Masatoshi Narita - Pharmaceuticals and Medical Devices Agency, Japan
Keith Wonnacott, PhD - US Food and Drug Administration, CBER
Yongjie Zhou, MD, PhD - US Food and Drug Administration, CBER
For more information, click here.
Hot Topic Symposium on Anti-CTLA-4
November 2, 2008 - San Diego, CA
Features invited speakers, panel discussion/debate and audience questions regarding "Anti-CTLA-4: Issues in Development and Regulatory Approval."
Confirmed Faculty:
Michael B. Atkins, MD - Beth Israel Deaconess Medical Center
Steven Hirschfeld, MD, PhD - National Institute of Child Health and Human Development
Ulrich Keilholz, MD - Charité CBF
Antoni Ribas, MD - UCLA Medical Center
Mario Sznol, MD - Yale University School of Medicine
Jeffrey S. Weber, MD, PhD - H. Lee Moffitt Cancer Center and Research Institute
There is no fee to attend this session, but registration is required.
Workshop on Cancer and Inflammation
October 30, 2008 - San Diego, CA
Small group, interactive workshop assembles thought-leaders in the field of cancer biologics to discuss inflammation and its role in cancer with an expected results publication following the program.
Confirmed Faculty:
Robert T. Abraham, PhD - Wyeth
Michele Carbone, MD, PhD - Cancer Research Center of Hawaii
Yen-Ching Karen Chen, ScD, SM - National Taiwan University
George Coukos, MD, PhD - University of Pennsylvania Medical Center
Lisa M. Coussens, PhD - University of California, San Francisco
Steven Dubinett, MD - University of California, Los Angeles
Emad M. El-Omar, MB ChB, MD - University of Aberdeen
Bernard A. Fox, PhD - Earle A. Chiles Research Institute
Michael Karin, PhD - University of California, San Diego
Arthur M. Krieg, MD - Pfizer, Inc.
Michael T. Lotze, MD - University of Pittsburgh Cancer Institute
Sandra Demaria, MD - New York University
Eva Szabo, MD - National Cancer Institute, NIH
Giorgio Trinchieri, MD - National Cancer Institute, NIH
Ena Wang, MD - National Institutes of Health / CC
George J. Weiner, MD - University of Iowa
For more information, click here.
Primer on Tumor Immunology and Biological Therapy
October 30, 2008 - San Diego, CA
Experts provide a current overview of immunology as it applies to cancer etiology, biology and therapy.
Confirmed Faculty:
James P. Allison, PhD - Memorial Sloan-Kettering Cancer Center
David A. Cheresh, PhD - University of California, San Diego
Phillip D. Greenberg, MD - Fred Hutchison Cancer Research Center and University of Washington
Patrick Hwu, MD - MD Anderson Cancer Center
Michael D. Kalos, PhD - University of Washington
Kim A. Margolin, MD - University of Washington
William J. Murphy, PhD - University of California, Davis
Lee M. Nadler, MD - Dana-Farber Cancer Institute
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research
Shimon Sakaguchi, MD, PhD - Kyoto Univeristy, Japan
Mario Sznol, MD - Yale University School of Medicine
Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute
For more information, click here.
23rd Annual Meeting
October 31 – November 2, 2008 – San Diego, CA
Gathers the leading experts in immunotherapy/biological therapy of cancer from all venues for education and exchange of cutting edge preclinical and clinical data between basic scientists and clinicians.
Confirmed Faculty:
John C. Byrd, MD - The Ohio State University
Helen Chen, MD - National Cancer Institute, CTEP, NIH
Thomas A. Davis, MD - Celldex Therapeutics, Inc.
John R. Desjarlais, PhD - Xencor, Inc.
Madhav Dhodapkar, MD - The Rockefeller University
Glenn Dranoff, MD - Dana-Farber Cancer Institute
Thomas F. Gajewski, MD, PhD - University of Chicago
Helen E. Heslop, MD - Baylor College of Medicine
Michael C.V. Jensen, MD - City of Hope, Beckman Research Institute
W. Martin Kast, PhD - University of Southern California
Ilona Kryczek, PhD - University of Michigan
Greg Lazar, PhD - Xencor, Inc.
William J. Murphy, PhD - University of California, Davis
Martin Oft - Schering-Plough Biopharma (formerly DNAX)
Giorgio Parmiani, MD - San Raffaele Foundation
David Raulet, PhD - University of California, Berkeley
Nicholas P. Restifo, MD - National Cancer Institute, NIH
Jeffrey Schlom, PhD - National Cancer Institute, NIH
Robert D. Schreiber, PhD - Washington University in St. Louis
Hideaki Tahara, MD, PhD - University of Tokyo
Giorgio Trinchieri, MD - National Cancer Institute, NIH
Pierre van der Bruggen, PhD - Ludwig Institute for Cancer Research
Max Wicha, MD - University of Michigan
Jon M. Wigginton, MD - Merck & Co., Inc.
Weiping Zou, MD, PhD - University of Michigan
For more information, click here.
Mark Your Calendars!
iSBTc 24th Annual Meeting
October 29 - November 1, 2009
Washington DC